Skip to main content

European study of clinical, health economic and quality of life outcomes in Haemophilia treatment

Objective

This study has been designed to evaluate the quality of haemophilia care in Europe to describe the Sol of European haemophiliacs and to estimate the costs needed to attain these levels of quality of life. About 2040 Patients will be recruited con-seductively from haemophilia comprehensive care centres from 22 Countries. The Study will consist of a Sol Study, Cost-of-Illness-, Cost-Effectiveness- and Cost-Utility-Analysis to perform total costs due to haemophilia, to compare alternative treatments and to determine patient's preferences. Haemophiliac patients from 4 years on will be stratified according to following characteristics: severity of haemophilia, presence of inhibitors, treatment schemes. Clinical and health economic data will be assessed at baseline and prospectively over a 6-month follow-up period. In addition the patients fill in a diary during the follow-up period.

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

LUDWIG-MAXIMILIANS UNIVERSITY OF MUNICH
Address
Geschwister-scholl-platz 1
80539 Muenchen
Germany

Participants (7)

MEDICAL ECONOMICS RESEARCH GROUP
Germany
Address
Paul-gerhardt-allee 42
81245 Muenchen
NATIONAL MEDICAL CENTER
Hungary
Address
Vagany U 2 Fsz
1135 Budapest
OXFORD RADCLIFFE HOSPITAL NHS TRUST
United Kingdom
Address
Off Headley Way, Manor House
OX3 9DU Oxford/headington
THE UNIVERSITY OF MILANO
Italy
Address
Via Festa Del Perdono 7
20122 Milano
UNIVERSITY HOSPITAL MAS
Sweden
Address
Soedra Foerstadsgatan
20502 Malmoe
UNIVERSITY OF HAMBURG
Germany
Address
Martinistraße 52
20246 Hamburg
UNIVERSITY OF MEDICINE AND PHARMACY VICTOR BABES TIMISOARA
Romania
Address
2Nd, P-ta Eftimie Murgu
1900 Timisoara